IL6 and cancer: A retrospective cohort study of 2052 hospitalized patients with COVID-19 showed that inflammatory factors (highly sensitive CRP, procalcitonin) and cytokines (IL-2R, IL-6, IL-8) were higher in cancer patients compared with noncancer patients (30).